Gavi, the Vaccine Alliance, appointed Cambridge Economic Policy Associates (CEPA) to conduct an evaluation of Gavi’s Eligibility and Transition and Co-financing Policies (“ELTRACO Policies”).
Gavi, the Vaccine Alliance, appointed Cambridge Economic Policy Associates (CEPA) to conduct an evaluation of Gavi’s Eligibility and Transition and Co-financing Policies (“ELTRACO Policies”).
The focus has been an assessment of two separate, but interlinked policies with four principal objectives which are to:
The evaluation will contribute to an ongoing review and update of Gavi’s financing and support policies in 2019-20. This review is, in turn, part of the operationalisation of ‘Gavi 5.0’, Gavi’s strategy for the period 2021-25. The ELTRACO Policies are both considered to be of strategic importance in the context of Gavi 5.0 development and planning especially in the context of a changing global health landscape.
Co-financing means that countries contribute to the cost of Gavi-supported vaccines by financing some of the required vaccine doses.
Eligibility and transitioning policy
Gavi supports the world’s lowest-income countries. The eligibility and transition policy sets out the criteria that determine which countries are eligible to apply for different forms of Gavi support.
